Saltar al contenido
Merck

Role of inositol-1,4,5-trisphosphate receptor in the regulation of calcium transients in neonatal rat ventricular myocytes.

Journal of pharmacological sciences (2014-09-23)
Zheng Zeng, Heping Zhang, Na Lin, Man Kang, Yuanyuan Zheng, Chen Li, Pingxiang Xu, Yongquan Wu, Dali Luo
RESUMEN

This study determined the regulatory effect of inositol 1,4,5-trisphosphate receptors (IP3Rs) on the basal Ca(2+) transients in cardiomyocytes. In cultured neonatal rat ventricular myocytes (NRVMs) at different densities, we used confocal microscopy to assess the effect of IP3Rs on the endogenous spontaneous Ca(2+) oscillations through specific activation of IP3Rs with myo-IP3 hexakis (butyryloxymethyl) ester (IP3BM), a membrane permeable IP3, and interference of IP3R expression with shRNA. We found that NRVMs at the monolayer state displayed coordinated Ca(2+) transients with less rate, shorter duration, and higher amplitude compared to single NRVMs. In addition, monolayer NRVMs exhibited 4 or 10 times more increased Ca(2+) transients in response to phenylephrine, an α-adrenergic receptor agonist, or IP3BM than single NRVMs did, while the transient pattern remained unaltered, suggesting that the sensitivity of intracellular Ca(2+) response to IP3R activation is different between single and monolayer NRVMs. However, interference of IP3R expression with shRNA reduced the frequency and amplitude of the spontaneous Ca(2+) fluctuates similarly in both densities of NRVMs, resembling the effects of ryanodine receptor inhibition by ryanodine or tetracaine. Our findings suggest that IP3Rs are involved, in part, in the regulation of native Ca(2+) transients, in profiles of their initiation and Ca(2+) release extent, in developing cardiomyocytes. In addition, caution should be paid in evaluating the behavior of Ca(2+) signaling in primary cultured cardiomyocytes at different densities.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
(R)-(−)-Phenylephrine hydrochloride, powder
Phenylephrine, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
3-[(1R)-1-Hydroxy-2-(methylamino)ethyl]phenol, AldrichCPR
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Itpr1
Sigma-Aldrich
MISSION® esiRNA, targeting human ITPR3
Sigma-Aldrich
MISSION® esiRNA, targeting human ITPR1
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Itpr3